Adverum Biotechnologies
ADVM
ADVM
57 hedge funds and large institutions have $104M invested in Adverum Biotechnologies in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
48% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 23
Holders
57
Holding in Top 10
2
Calls
$125K
Puts
–
Top Buyers
| 1 | +$7.95M | |
| 2 | +$6.18M | |
| 3 | +$975K | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$509K |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$451K |
Top Sellers
| 1 | -$3.04M | |
| 2 | -$1.92M | |
| 3 | -$1.2M | |
| 4 |
BlackRock
New York
|
-$1.01M |
| 5 |
NM
Newtyn Management
New York
|
-$840K |